Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2026)
Roivant Sciences (ROIV) posted Interest & Investment Income of $36.92 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 23.6% from $48.32 million a year earlier and down 10.3% from the prior quarter.
Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Roivant Sciences was $166.71 million, down 28.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $178.11 million, down 31.1% from FY2025.
- Annual Interest & Investment Income shows a four-year compound annual growth rate of 368.7% (FY2022 to FY2026).
- In prior fiscal years, Roivant Sciences' Interest & Investment Income was $258.38 million in FY2025 (+76.5%), $146.43 million in FY2024 (+355.0%), $32.18 million in FY2023 and $369,000 in FY2022.
- The fiscal Q1 2027 figure stands as the lowest quarterly Interest & Investment Income since fiscal Q3 2024.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last six quarters, with growth averaging 37.6% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q1 2024, with growth of 743.8%; the weakest was fiscal Q2 2026, with a decline of 35.0%.
- According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $41.18 million (Q4 2026), $43.27 million (Q3 2026) and $45.34 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Roivant Sciences | 26.37 Bn | 10.01 Bn | 1.16 Mn | 36.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.92 Mn |
| Mar 31, 2026 | 41.18 Mn |
| Dec 31, 2025 | 43.27 Mn |
| Sep 30, 2025 | 45.34 Mn |
| Jun 30, 2025 | 48.32 Mn |
| Mar 31, 2025 | 54.62 Mn |
| Dec 31, 2024 | 61.85 Mn |
| Sep 30, 2024 | 69.77 Mn |
| Jun 30, 2024 | 72.13 Mn |
| Mar 31, 2024 | 83.46 Mn |
| Dec 31, 2023 | 31.95 Mn |
| Sep 30, 2023 | 14.30 Mn |
| Jun 30, 2023 | 16.72 Mn |
| Mar 31, 2023 | 14.28 Mn |
| Dec 31, 2022 | 10.25 Mn |
| Sep 30, 2022 | 5.67 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Mar 31, 2022 | 170,000.00 |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 62,000.00 |
Roivant Sciences Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();